Carboplatin desensitization in the era of target therapies: still worthwhile?

Autor: Dassi N; Department of Pediatrics' Oncology, IOP-GRAACC-Federal University of Sao Paulo, Sao Paulo, Brazil., da Cunha FS; Department of Pediatrics' Allergy, Immunology, and Rheumatology- Federal University of Sao Paulo, Sao Paulo, Brazil., Cappellano AM; Department of Pediatrics' Oncology, IOP-GRAACC-Federal University of Sao Paulo, Sao Paulo, Brazil. andreacappellano@graacc.org.br., de Araujo CA; Department of Pediatrics' Allergy, Immunology, and Rheumatology- Federal University of Sao Paulo, Sao Paulo, Brazil., de Aquino DNS; Department of Pediatrics' Allergy, Immunology, and Rheumatology- Federal University of Sao Paulo, Sao Paulo, Brazil., de Almeida DB; Department of Pediatrics' Oncology, IOP-GRAACC-Federal University of Sao Paulo, Sao Paulo, Brazil., da Silva NS; Department of Pediatrics' Oncology, IOP-GRAACC-Federal University of Sao Paulo, Sao Paulo, Brazil., Ensina LFC; Department of Pediatrics' Allergy, Immunology, and Rheumatology- Federal University of Sao Paulo, Sao Paulo, Brazil.

Publikováno v: Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery [Childs Nerv Syst] 2024 Dec; Vol. 40 (12), pp. 4259-4264. Date of Electronic Publication: 2024 Aug 07.